This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Momenta Pharmaceuticals, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations of Nicholas A. Cilfone
Introduction
Nicholas A. Cilfone is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of immunology through his innovative research and development of antibodies.
Latest Patents
Nicholas A. Cilfone holds a patent for "FcRn antibodies and methods of use thereof." This invention features antibodies that bind to the human neonatal Fc receptor (FcRn). These anti-FcRn antibodies are useful for promoting the clearance of autoantibodies, suppressing antigen presentation, and blocking immune responses. They also have applications in treating immunological diseases, such as autoimmune diseases. Additionally, these antibodies can decrease pathogenic antibody transport across the placenta and enhance antibody catabolism in pregnant subjects.
Career Highlights
Nicholas A. Cilfone is currently associated with Momenta Pharmaceuticals, Inc., where he continues to advance his research in antibody development. His work has the potential to impact the treatment of various immunological conditions significantly.
Collaborations
Some of his notable coworkers include Leona E. Ling and Darrell Nix, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Nicholas A. Cilfone's innovative work in the field of immunology, particularly with FcRn antibodies, showcases his dedication to advancing medical science and improving patient outcomes. His contributions are vital in the ongoing fight against autoimmune diseases and other immunological challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile